In the year following the introduction of our first section editors, the number of submissions to Molecular Oncology has continued to grow apace. To better reflect the increasing size of the journal, I am now pleased to announce the appointment of two new section editors, Heike Allgayer and Joachim Sch€ uz. Heike is Full Professor and Director, Department of Experimental Surgery-Cancer Metastasis and Vice Director, Centre for Biomedicine and Medical Technology Mannheim (CBTM), Medical Faculty Mannheim, Ruprecht Karls University, Heidelberg, Germany. Heike's main research areas of expertise include metastasis, translational research, and targeted therapy. Joachim Sch€ uz is Head of Section (Environment and Radiation) at the International Agency for Research on Cancer (IARC), Lyon, France, and is currently coordinator of Cancer Prevention Europe (CPE), a consortium of leading organizations across the whole of Europe that aims at reducing morbidity and mortality from cancer in European populations through prevention and earlier diagnosis of the disease. Joachim's areas of expertise include cancer epidemiology, radiation epidemiology, environmental exposures, and biostatistics.
We are delighted to welcome both editors to the team, as their experience and dedication will be instrumental to the continued success of the journal.
This month also sees the appointment of Maria Papatriantafyllou as a full-time Editorial Manager of Molecular Oncology. Maria will manage the day-today operation of the journal and will work closely with our authors, reviewers, editors, and publishing partners. She brings considerable editorial experience to our journal, having worked previously on Nature Reviews Immunology and Nature Reviews Molecular Cell Biology, as well as our sister journal, FEBS Letters. Maria obtained her PhD at the German Cancer Research Centre, where she studied the regulation of T-cell responses by Dickkopf-3.
I look forward to working with Maria and would like to warmly welcome her to the journal on behalf of the whole team.
Finally, our sister journal, FEBS Open Bio, has also seen a rise in submissions. Duncan Wright, who has previously worked as Editorial Associate across both journals, will be leaving Molecular Oncology to take up a full-time position as Editorial Manager of FEBS Open Bio. It has been a great pleasure for me to work with such a talented young colleague.
Section editors
Heike Allgayer:
Heike Allgayer received her MD and Dr. med. (summa cum laude) at Ludwig-Maximilians University Munich in 1995/1996, and her PhD (in molecular biology) at the University of Houston-MD Anderson Cancer Center in 1999. As a board-certified surgeon and molecular biologist, she sees her mission in combating cancer metastasis, bridging basic molecular research with clinically relevant hypotheses as a dedicated translational researcher. Her primary research interests include molecular determinants defining metastasis, tumor-associated proteases, microRNAs in metastasis, molecular determinants promoting personalized therapy against metastasis, molecular staging, translational metastasis research, and metastasis prevention. 
